| Application no. and date | 17859433.9 (espacenet) (Federated) (European Patent Register), 20171009 | | Patent/reg. no. and date | DK/EP 3525813, 20240417 | | Publication date | 20190821 | | Priority no. and date | US 201662406598 P, 20161011 | | EP pub. no. and date |
EP 3525813 20190821 | | Effective date | | | Applicant/owner | Razi Holdings, Inc., 4 Research Court, Suite 300
Rockville, MD 20850, US,
The University of Maryland, UM Ventures
7809 Regents Dr., 0134 Lee Bldg.
College Park, MD 20742, US | | Applicant ref. no. | | | Inventor | AMAN, Mohammad Javad, 12809 Circle Drive
Rockville, Maryland 20850, US,
HOLTSBERG, Frederick Wayne, 4625 Buffington Lane
Taneytown, Maryland 21787, US,
ZHAO, Xuelian, 363 Community Center Avenue
Gaithersburg, Maryland 20878, US,
LI, Yuxing, 14242 Kings Crossing Boulevard
Boyds, Maryland 20841, US,
HOWELL, Katie A., 8626 Summer Waves Way
Laurel, MD 20723, US | | Representative | | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61K 39/42 (2006.01) , C07K 16/10 (2006.01) | | Title | BROADLY NEUTRALIZING ANTIBODY TARGETING THE EBOLAVIRUS GLYCOPROTEIN INTERNAL FUSION LOOP | | Int. application no. | US2017055795 | | Int. publication no. | WO2018071345 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
